Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study.

van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE.

Bull World Health Organ. 2011 Sep 1;89(9):632-9. doi: 10.2471/BLT.11.086462. Epub 2011 May 20.

2.

Validation of indirect tuberculosis treatment adherence measures in a resource-constrained setting.

Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E, van Leth F.

Int J Tuberc Lung Dis. 2014 Jul;18(7):804-9. doi: 10.5588/ijtld.13.0675.

PMID:
24902556
3.

Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT Jr.

Am J Hypertens. 1996 Aug;9(8):719-25.

PMID:
8862216
4.

Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.

Brain C, Sameby B, Allerby K, Lindström E, Eberhard J, Burns T, Waern M.

Eur Neuropsychopharmacol. 2014 Feb;24(2):215-22. doi: 10.1016/j.euroneuro.2013.11.013. Epub 2013 Dec 4.

PMID:
24359935
5.

Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.

Manders AJ, Banerjee A, van den Borne HW, Harries AD, Kok GJ, Salaniponi FM.

Int J Tuberc Lung Dis. 2001 Sep;5(9):838-42.

PMID:
11573895
7.

Development and validation of a tuberculosis medication adherence scale.

Yin X, Tu X, Tong Y, Yang R, Wang Y, Cao S, Fan H, Wang F, Gong Y, Yin P, Lu Z.

PLoS One. 2012;7(12):e50328. doi: 10.1371/journal.pone.0050328. Epub 2012 Dec 12.

8.

Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.

Fallab-Stubi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M.

Int J Tuberc Lung Dis. 1998 Jul;2(7):525-30.

PMID:
9661817
9.

Prospective single-arm interventional pilot study to assess a smartphone-based system for measuring and supporting adherence to medication.

Molton JS, Pang Y, Wang Z, Qiu B, Wu P, Rahman-Shepherd A, Ooi WT, Paton NI.

BMJ Open. 2016 Dec 20;6(12):e014194. doi: 10.1136/bmjopen-2016-014194.

10.

A step-wise approach to find a valid and feasible method to detect non-adherence to tuberculosis drugs.

Ruslami R, van Crevel R, van de Berge E, Alisjahbana B, Aarnoutse RE.

Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1083-7.

PMID:
19062699
11.

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.

Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R.

Med Care. 1999 Sep;37(9):846-57.

PMID:
10493464
12.

Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans.

Schoenthaler A, Ogedegbe G.

Ann Pharmacother. 2008 May;42(5):647-52. doi: 10.1345/aph.1K640. Epub 2008 Apr 8.

PMID:
18397971
13.

Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators.

Zeller A, Ramseier E, Teagtmeyer A, Battegay E.

Hypertens Res. 2008 Nov;31(11):2037-43. doi: 10.1291/hypres.31.2037.

PMID:
19098375
14.

Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.

Belknap R, Weis S, Brookens A, Au-Yeung KY, Moon G, DiCarlo L, Reves R.

PLoS One. 2013;8(1):e53373. doi: 10.1371/journal.pone.0053373. Epub 2013 Jan 7.

15.

Assessing adherence to dermatology treatments: a review of self-report and electronic measures.

Greenlaw SM, Yentzer BA, O'Neill JL, Balkrishnan R, Feldman SR.

Skin Res Technol. 2010 May;16(2):253-8. doi: 10.1111/j.1600-0846.2010.00431.x. Review.

16.

The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication.

Kheir N, Greer W, Yousif A, Al-Geed H, Okkah RA, Zirie M, Sandridge A, Zaidan M.

Patient Prefer Adherence. 2010 Jul 21;4:247-54.

17.

Testing a nurse-tailored HIV medication adherence intervention.

Holzemer WL, Bakken S, Portillo CJ, Grimes R, Welch J, Wantland D, Mullan JT.

Nurs Res. 2006 May-Jun;55(3):189-97.

PMID:
16708043
18.

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD.

Am J Med. 2001 Jun 1;110(8):610-5.

PMID:
11382368
19.

Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.

Doró P, Benko R, Czakó A, Matuz M, Thurzó F, Soós G.

Int J Clin Pharm. 2011 Aug;33(4):690-5. doi: 10.1007/s11096-011-9529-7. Epub 2011 Jun 21.

PMID:
21691882
20.

Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.

Egwaga S, Mkopi A, Range N, Haag-Arbenz V, Baraka A, Grewal P, Cobelens F, Mshinda H, Lwilla F, van Leth F.

BMC Med. 2009 Dec 21;7:80. doi: 10.1186/1741-7015-7-80.

Supplemental Content

Support Center